Cargando…
Assessment of the Therapeutic Potential of Metallothionein-II Application in Focal Cerebral Ischemia In Vitro and In Vivo
Metallothionein-II (MT-II) is an ubiquitously expressed small-molecular-weight protein and highly induced in various species and tissues upon stress, inflammation, and ischemia. MT-deficiency exacerbates ischemic injury in rodent stroke models in vitro and in vivo. However, there is conflicting data...
Autores principales: | Eidizadeh, Abass, Khajehalichalehshtari, Manuel, Freyer, Dorette, Trendelenburg, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682799/ https://www.ncbi.nlm.nih.gov/pubmed/26658636 http://dx.doi.org/10.1371/journal.pone.0144035 |
Ejemplares similares
-
Focusing on the protective effects of metallothionein-I/II in cerebral ischemia
por: Eidizadeh, Abass, et al.
Publicado: (2016) -
Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice
por: Harhausen, Denise, et al.
Publicado: (2010) -
In vitro and in vivo studies on the degradation of metallothionein.
por: Klaassen, C D, et al.
Publicado: (1994) -
Baicalin's Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative Effects In Vitro and In Vivo
por: Cheng, Fafeng, et al.
Publicado: (2013) -
Renal effects of metallothionein induction by zinc in vitro and in vivo
por: Schanz, Moritz, et al.
Publicado: (2017)